Selected research
Market Analysis & Forecast
Global Velcade Market Analysis and Forecast 2026-2032
Market perspective
The global Velcade market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Velcade is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Velcade is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Velcade is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Velcade is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Velcade include Ben Venue Laboratories, Hospira, Beijing Shuanglu Pharmaceutical, Guangdong Lingnan Pharmaceutical, Sinopharm Pharmaceutical, Harbin Sanlian Pharmaceutical, XISUN, Nanjing Zhengda Tianqing Pharmaceutical and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Velcade, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Velcade, also provides the sales of main regions and countries. Of the upcoming market potential for Velcade, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Velcade sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Velcade market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Velcade sales, projected growth trends, production technology, application and end-user industry.
Velcade Segment by Company
Ben Venue Laboratories
Hospira
Beijing Shuanglu Pharmaceutical
Guangdong Lingnan Pharmaceutical
Sinopharm Pharmaceutical
Harbin Sanlian Pharmaceutical
XISUN
Nanjing Zhengda Tianqing Pharmaceutical
Johnson & Johnson
Shandong Luoxin Pharmaceutical Group
Shanxi Pude Pharmaceutical
Wuhan Renfu Pharmaceutical
Takeda
Xi'an Yangsen Pharmaceutical
Velcade Segment by Type
1.0 Mg Injection
3.5 Mg Injection
Velcade Segment by Application
Multiple Myeloma
Mantle Cell Lymphoma
Velcade Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Velcade market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Velcade and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Velcade.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Velcade in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Velcade manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Velcade sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1.0 Mg Injection
- 3.5 Mg Injection
Applications
- Multiple Myeloma
- Mantle Cell Lymphoma
Companies covered
- Ben Venue Laboratories
- Hospira
- Beijing Shuanglu Pharmaceutical
- Guangdong Lingnan Pharmaceutical
- Sinopharm Pharmaceutical
- Harbin Sanlian Pharmaceutical
- XISUN
- Nanjing Zhengda Tianqing Pharmaceutical
- Johnson & Johnson
- Shandong Luoxin Pharmaceutical Group
- Shanxi Pude Pharmaceutical
- Wuhan Renfu Pharmaceutical
- Takeda
- Xi'an Yangsen Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Velcade Market by Type
- 1.2.1 Global Velcade Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 1.0 Mg Injection
- 1.2.3 3.5 Mg Injection
- 1.3 Velcade Market by Application
- 1.3.1 Global Velcade Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Multiple Myeloma
- 1.3.3 Mantle Cell Lymphoma
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Velcade Market Dynamics
- 2.1 Velcade Industry Trends
- 2.2 Velcade Industry Drivers
- 2.3 Velcade Industry Opportunities and Challenges
- 2.4 Velcade Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Velcade Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Velcade Revenue by Region
- 3.2.1 Global Velcade Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Velcade Revenue by Region (2021-2026)
- 3.2.3 Global Velcade Revenue by Region (2027-2032)
- 3.2.4 Global Velcade Revenue Market Share by Region (2021-2032)
- 3.3 Global Velcade Sales Estimates and Forecasts 2021-2032
- 3.4 Global Velcade Sales by Region
- 3.4.1 Global Velcade Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Velcade Sales by Region (2021-2026)
- 3.4.3 Global Velcade Sales by Region (2027-2032)
- 3.4.4 Global Velcade Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Velcade Revenue by Manufacturers
- 4.1.1 Global Velcade Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Velcade Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Velcade Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Velcade Sales by Manufacturers
- 4.2.1 Global Velcade Sales by Manufacturers (2021-2026)
- 4.2.2 Global Velcade Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Velcade Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Velcade Sales Price by Manufacturers (2021-2026)
- 4.4 Global Velcade Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Velcade Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Velcade Manufacturers, Product Type & Application
- 4.7 Global Velcade Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Velcade Market CR5 and HHI
- 4.8.2 2025 Velcade Tier 1, Tier 2, and Tier 3
5 Velcade Market by Type
- 5.1 Global Velcade Revenue by Type
- 5.1.1 Global Velcade Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Velcade Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Velcade Revenue Market Share by Type (2021-2032)
- 5.2 Global Velcade Sales by Type
- 5.2.1 Global Velcade Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Velcade Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Velcade Sales Market Share by Type (2021-2032)
- 5.3 Global Velcade Price by Type
6 Velcade Market by Application
- 6.1 Global Velcade Revenue by Application
- 6.1.1 Global Velcade Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Velcade Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Velcade Revenue Market Share by Application (2021-2032)
- 6.2 Global Velcade Sales by Application
- 6.2.1 Global Velcade Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Velcade Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Velcade Sales Market Share by Application (2021-2032)
- 6.3 Global Velcade Price by Application
7 Company Profiles
- 7.1 Ben Venue Laboratories
- 7.1.1 Ben Venue Laboratories Company Information
- 7.1.2 Ben Venue Laboratories Business Overview
- 7.1.3 Ben Venue Laboratories Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Ben Venue Laboratories Velcade Product Portfolio
- 7.1.5 Ben Venue Laboratories Recent Developments
- 7.2 Hospira
- 7.2.1 Hospira Company Information
- 7.2.2 Hospira Business Overview
- 7.2.3 Hospira Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Hospira Velcade Product Portfolio
- 7.2.5 Hospira Recent Developments
- 7.3 Beijing Shuanglu Pharmaceutical
- 7.3.1 Beijing Shuanglu Pharmaceutical Company Information
- 7.3.2 Beijing Shuanglu Pharmaceutical Business Overview
- 7.3.3 Beijing Shuanglu Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Beijing Shuanglu Pharmaceutical Velcade Product Portfolio
- 7.3.5 Beijing Shuanglu Pharmaceutical Recent Developments
- 7.4 Guangdong Lingnan Pharmaceutical
- 7.4.1 Guangdong Lingnan Pharmaceutical Company Information
- 7.4.2 Guangdong Lingnan Pharmaceutical Business Overview
- 7.4.3 Guangdong Lingnan Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Guangdong Lingnan Pharmaceutical Velcade Product Portfolio
- 7.4.5 Guangdong Lingnan Pharmaceutical Recent Developments
- 7.5 Sinopharm Pharmaceutical
- 7.5.1 Sinopharm Pharmaceutical Company Information
- 7.5.2 Sinopharm Pharmaceutical Business Overview
- 7.5.3 Sinopharm Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Sinopharm Pharmaceutical Velcade Product Portfolio
- 7.5.5 Sinopharm Pharmaceutical Recent Developments
- 7.6 Harbin Sanlian Pharmaceutical
- 7.6.1 Harbin Sanlian Pharmaceutical Company Information
- 7.6.2 Harbin Sanlian Pharmaceutical Business Overview
- 7.6.3 Harbin Sanlian Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Harbin Sanlian Pharmaceutical Velcade Product Portfolio
- 7.6.5 Harbin Sanlian Pharmaceutical Recent Developments
- 7.7 XISUN
- 7.7.1 XISUN Company Information
- 7.7.2 XISUN Business Overview
- 7.7.3 XISUN Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 XISUN Velcade Product Portfolio
- 7.7.5 XISUN Recent Developments
- 7.8 Nanjing Zhengda Tianqing Pharmaceutical
- 7.8.1 Nanjing Zhengda Tianqing Pharmaceutical Company Information
- 7.8.2 Nanjing Zhengda Tianqing Pharmaceutical Business Overview
- 7.8.3 Nanjing Zhengda Tianqing Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Nanjing Zhengda Tianqing Pharmaceutical Velcade Product Portfolio
- 7.8.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments
- 7.9 Johnson & Johnson
- 7.9.1 Johnson & Johnson Company Information
- 7.9.2 Johnson & Johnson Business Overview
- 7.9.3 Johnson & Johnson Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Johnson & Johnson Velcade Product Portfolio
- 7.9.5 Johnson & Johnson Recent Developments
- 7.10 Shandong Luoxin Pharmaceutical Group
- 7.10.1 Shandong Luoxin Pharmaceutical Group Company Information
- 7.10.2 Shandong Luoxin Pharmaceutical Group Business Overview
- 7.10.3 Shandong Luoxin Pharmaceutical Group Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Shandong Luoxin Pharmaceutical Group Velcade Product Portfolio
- 7.10.5 Shandong Luoxin Pharmaceutical Group Recent Developments
- 7.11 Shanxi Pude Pharmaceutical
- 7.11.1 Shanxi Pude Pharmaceutical Company Information
- 7.11.2 Shanxi Pude Pharmaceutical Business Overview
- 7.11.3 Shanxi Pude Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Shanxi Pude Pharmaceutical Velcade Product Portfolio
- 7.11.5 Shanxi Pude Pharmaceutical Recent Developments
- 7.12 Wuhan Renfu Pharmaceutical
- 7.12.1 Wuhan Renfu Pharmaceutical Company Information
- 7.12.2 Wuhan Renfu Pharmaceutical Business Overview
- 7.12.3 Wuhan Renfu Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Wuhan Renfu Pharmaceutical Velcade Product Portfolio
- 7.12.5 Wuhan Renfu Pharmaceutical Recent Developments
- 7.13 Takeda
- 7.13.1 Takeda Company Information
- 7.13.2 Takeda Business Overview
- 7.13.3 Takeda Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Takeda Velcade Product Portfolio
- 7.13.5 Takeda Recent Developments
- 7.14 Xi'an Yangsen Pharmaceutical
- 7.14.1 Xi'an Yangsen Pharmaceutical Company Information
- 7.14.2 Xi'an Yangsen Pharmaceutical Business Overview
- 7.14.3 Xi'an Yangsen Pharmaceutical Velcade Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Xi'an Yangsen Pharmaceutical Velcade Product Portfolio
- 7.14.5 Xi'an Yangsen Pharmaceutical Recent Developments
8 North America
- 8.1 North America Velcade Market Size by Type
- 8.1.1 North America Velcade Revenue by Type (2021-2032)
- 8.1.2 North America Velcade Sales by Type (2021-2032)
- 8.1.3 North America Velcade Price by Type (2021-2032)
- 8.2 North America Velcade Market Size by Application
- 8.2.1 North America Velcade Revenue by Application (2021-2032)
- 8.2.2 North America Velcade Sales by Application (2021-2032)
- 8.2.3 North America Velcade Price by Application (2021-2032)
- 8.3 North America Velcade Market Size by Country
- 8.3.1 North America Velcade Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Velcade Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Velcade Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Velcade Market Size by Type
- 9.1.1 Europe Velcade Revenue by Type (2021-2032)
- 9.1.2 Europe Velcade Sales by Type (2021-2032)
- 9.1.3 Europe Velcade Price by Type (2021-2032)
- 9.2 Europe Velcade Market Size by Application
- 9.2.1 Europe Velcade Revenue by Application (2021-2032)
- 9.2.2 Europe Velcade Sales by Application (2021-2032)
- 9.2.3 Europe Velcade Price by Application (2021-2032)
- 9.3 Europe Velcade Market Size by Country
- 9.3.1 Europe Velcade Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Velcade Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Velcade Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Velcade Market Size by Type
- 10.1.1 China Velcade Revenue by Type (2021-2032)
- 10.1.2 China Velcade Sales by Type (2021-2032)
- 10.1.3 China Velcade Price by Type (2021-2032)
- 10.2 China Velcade Market Size by Application
- 10.2.1 China Velcade Revenue by Application (2021-2032)
- 10.2.2 China Velcade Sales by Application (2021-2032)
- 10.2.3 China Velcade Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Velcade Market Size by Type
- 11.1.1 Asia Velcade Revenue by Type (2021-2032)
- 11.1.2 Asia Velcade Sales by Type (2021-2032)
- 11.1.3 Asia Velcade Price by Type (2021-2032)
- 11.2 Asia Velcade Market Size by Application
- 11.2.1 Asia Velcade Revenue by Application (2021-2032)
- 11.2.2 Asia Velcade Sales by Application (2021-2032)
- 11.2.3 Asia Velcade Price by Application (2021-2032)
- 11.3 Asia Velcade Market Size by Country
- 11.3.1 Asia Velcade Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Velcade Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Velcade Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Velcade Market Size by Type
- 12.1.1 SAMEA Velcade Revenue by Type (2021-2032)
- 12.1.2 SAMEA Velcade Sales by Type (2021-2032)
- 12.1.3 SAMEA Velcade Price by Type (2021-2032)
- 12.2 SAMEA Velcade Market Size by Application
- 12.2.1 SAMEA Velcade Revenue by Application (2021-2032)
- 12.2.2 SAMEA Velcade Sales by Application (2021-2032)
- 12.2.3 SAMEA Velcade Price by Application (2021-2032)
- 12.3 SAMEA Velcade Market Size by Country
- 12.3.1 SAMEA Velcade Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Velcade Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Velcade Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Velcade Value Chain Analysis
- 13.1.1 Velcade Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Velcade Production Mode & Process
- 13.2 Velcade Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Velcade Distributors
- 13.2.3 Velcade Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst